GENEVA, July 9 -- CF PHARMTECH USA, INC. filed a patent application (CN2025/136433) for “DRY POWDER COMPOSITION OF TREPROSTINIL DERIVATIVE, AND USE THEREOF”. With publication no. WO/2026/144627, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/216
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....